Wang, T., Zwicker, J.I., Ay, C., Pabinger, I., Falanga, A., Antic, D., Noble, S., Khorana, A.A., Carrier, M. and Meyer, G. (2019) The Use of Direct Oral Anticoagulants for Primary Thromboprophylaxis in Ambulatory Cancer Patients: Guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis, 17, 1772-1778.
https://doi.org/10.1111/jth.14564

has been cited by the following article:

• TITLE: Intracranial Venous and Mesenteric Vein Thrombosis in a Case of Lung Cancer with Brain, Bone, and Leptomeningeal Metastasis

  AUTHORS: Hongdan Shen, Xianhua Fu

  KEYWORDS: Venous Thromboembolism, Thromboprophylaxis, Cancer Management

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.9 No.1, December 25, 2019

  ABSTRACT: Cancer patients with venous thromboembolism (VTE) are not rare, and the second death cause in patients with cancer is VTE. Although VTE itself is associated with reduced survival particularly in cancer patients, many oncologists may not place enough importance in positive prevention of VTE. Here, we report the case of a 38-year-old male lung cancer patient with brain, bone and leptomeningeal metastasis who diagnosed as a consequential intracranial venous and mesenteric vein thrombosis. The evolution of headache has not been noted gradually, from which led to the underestimation of headache and without careful consideration on the possibility of suspected intracranial venous thrombosis. The problem of mesenteric vein thrombosis reflects the dilemma resulted from the potential risk of thrombogenesis and the high risk of hemorrhage. Preventive anticoagulation strategies are key means especially in patients with cancer, and the management problems of this condition are discussed.